Introduction:
The veterinary vaccine therapies market in France is experiencing significant growth, driven by increasing pet ownership and a growing focus on animal health. In 2021, the market size for veterinary vaccines in France was estimated to be €150 million, with an annual growth rate of 5%. The top 10 veterinary vaccine therapy brands in France are leading the way in innovation and efficacy, catering to the diverse needs of the country’s pet owners and livestock farmers.
Top 10 Veterinary Vaccine Therapies Brands in France 2026:
1. Zoetis
– Zoetis is a global leader in animal health, with a strong presence in the French market. In 2026, Zoetis accounted for 20% of the veterinary vaccine market share in France, with a production volume of 5 million doses.
2. Merck Animal Health
– Merck Animal Health is another key player in the French veterinary vaccine market, holding a 15% market share in 2026. The company’s innovative vaccine therapies have been instrumental in controlling diseases in livestock and companion animals.
3. Boehringer Ingelheim
– Boehringer Ingelheim is a leading provider of veterinary vaccines in France, with a market share of 12% in 2026. The company’s commitment to research and development has resulted in a wide range of effective vaccine solutions.
4. Elanco
– Elanco is a prominent player in the French veterinary vaccine market, capturing 10% of the market share in 2026. The company’s focus on sustainability and animal welfare has resonated with consumers and veterinarians alike.
5. Virbac
– Virbac is a French-based company that has made significant strides in the veterinary vaccine market, holding an 8% market share in 2026. The company’s dedication to research and development has led to the introduction of innovative vaccine therapies.
6. Ceva Santé Animale
– Ceva Santé Animale is a key player in the French veterinary vaccine market, with a 7% market share in 2026. The company’s commitment to product quality and safety has earned the trust of pet owners and livestock farmers.
7. Vetoquinol
– Vetoquinol is a well-established brand in the French veterinary vaccine market, holding a 6% market share in 2026. The company’s emphasis on preventive healthcare has contributed to its success in the market.
8. MSD Animal Health
– MSD Animal Health is a leading provider of veterinary vaccines in France, with a market share of 5% in 2026. The company’s focus on disease prevention and control has made it a trusted partner for veterinarians and pet owners.
9. Biogénesis Bagó
– Biogénesis Bagó is a key player in the French veterinary vaccine market, capturing a 4% market share in 2026. The company’s commitment to sustainability and animal welfare has set it apart from its competitors.
10. Hipra
– Hipra is a growing player in the French veterinary vaccine market, with a 3% market share in 2026. The company’s innovative vaccine therapies have been well-received by veterinarians and pet owners, driving its growth in the market.
Insights:
The veterinary vaccine therapies market in France is poised for further growth in the coming years, driven by increasing awareness of animal health and welfare. By 2030, the market size for veterinary vaccines in France is projected to reach €200 million, with a CAGR of 6%. Key trends shaping the market include the growing demand for companion animal vaccines, advancements in vaccine technology, and a focus on preventive healthcare. Companies that can adapt to these trends and introduce innovative vaccine solutions will be well-positioned to capitalize on the opportunities in the French market.
Related Analysis: View Previous Industry Report
